跳至主要内容
临床试验/NL-OMON22304
NL-OMON22304招募中不适用

ACTION-1: ACT guided heparinization during open abdominal aortic aneurysm (AAA) repair, a randomised trial.

Dijklander Ziekenhuis in collaboration with Amsterdam UMC, location VUmc and AMC0 个研究点目标入组 750 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
750

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Able to speak and read in local language of trial hospital.
  • Patients older than 18 years scheduled for elective, open repair of an iliac or abdominal aortic aneurysm distal of the SMA (DSAA segment C).
  • Implantation of a tube or bifurcation prosthesis.
  • Trans-abdominal or retroperitoneal surgical approach of aneurysm.
  • Able and willing to provide written informed consent.

排除标准

  • Not able to provide written informed consent.
  • Previous open or endovascular intervention on the abdominal aorta (previous surgery on other parts of the aorta or iliac arteries is not an exclusion criterion).
  • History of coagulation disorders, heparin induced thrombocytopenia (HIT), allergy for heparin or thrombocyte pathology.
  • Impaired renal function with EGFR below 30 ml/min.
  • Acute open AAA surgery.
  • Hybrid interventions.
  • Connective tissue disorders.
  • Dual anti-platelet therapy, which cannot be discontinued.
  • Life expectancy less than 2 years.
  • Inflammatory, mycotic or infected aneurysms
  • Allergy for protamine or fish protein

研究者

发起方
Dijklander Ziekenhuis in collaboration with Amsterdam UMC, location VUmc and AMC

相似试验